Opportunities in viral vector manufacturing arise from rising demand for GMP-grade materials and increasing gene therapy ...
Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...
KB407 utilizes a replication-defective HSV-1 vector to deliver full-length CFTR to the airway epithelium. The interim readout ...
AZoLifeSciences on MSN
Scientists Build the First Cellular Atlas of the World’s Deadliest Mosquito
The most dangerous animal in the world just got easier to study-and perhaps defeat one day.
The most dangerous animal in the world just got easier to study—and perhaps defeat one day. Researchers from Rockefeller ...
NYSE: VOYG] ("Voyager" or the "Company"), today announced financial results for the third quarter 2025. Delivered net sales ...
Despite the recent attention to the potential of developing and using gene therapy to treat several diseases, the therapy was ...
Beijing Tsingke Biotech Co., Ltd., a pioneer in molecular manufacturing, showcased its next-generation integrated platforms ...
The manuscript concerns a fundamental and controversial question in Trypanosoma brucei biology and the parasite life cycle, providing further evidence that slender bloodstream forms can indeed infect ...
Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback